Literature DB >> 17688405

Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts.

Bruna De Felice1, L F Ciarmiello, P Mondola, S Damiano, R Seru, C Argenziano, M Nacca, M Santoriello, C Garbi.   

Abstract

The p63 gene belongs to the p53 gene family and encodes for sequence-specific transcription factors. p63 has been characterized primarily in the context of epidermis where is implicated in the establishment of keratinocyte cell fate and in maintenance of epithelial self-renewal. DeltaNp63 isoform has been showed to be involved in several kinds of human tumors of epidermal origin, even nonmalignant, for the neoplastic and proliferative potential. Here, we report the differential expression and the cellular localization of the DeltaNp63 isoform in fibroblasts isolated from human keloids and hypertrophic scars compared to normal skin. Differently from hypertrophic scar, our results show that DeltaNp63 has a nuclear localization and is overexpressed only in keloid fibroblasts, suggesting an essential role of DeltaNp63 in vivo in human keloids. Consistent with our results, we hypothesize that DeltaNp63 overexpression may be oncogenic because of its ability to block the activity of p53 since p53 is underexpressed in fibroblasts from keloids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688405     DOI: 10.1089/dna.2007.0591

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  13 in total

1.  Keloids: pathogenesis, clinical features, and management.

Authors:  Chuma J Chike-Obi; Patrick D Cole; Anthony E Brissett
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

2.  A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.

Authors:  Bi-He Cai; Chung-Faye Chao; Hwang-Chi Lin; Hua-Ying Huang; Reiji Kannagi; Jang-Yi Chen
Journal:  J Biochem       Date:  2016-01-27       Impact factor: 3.387

3.  Silencing or not silencing p63 in cardiac fibroblast, risks and benefits.

Authors:  Guillermo Díaz-Araya; Jenaro Antonio Espitia-Corredor
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 4.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

5.  Keloid Biomarkers and Their Correlation With Immune Infiltration.

Authors:  Xufeng Yin; Wenbo Bu; Fang Fang; Kehui Ren; Bingrong Zhou
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

6.  Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.

Authors:  Bruna De Felice; Corrado Garbi; Margherita Santoriello; Alessandra Santillo; Robert R Wilson
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

7.  5-Fluorouracil treatment of problematic scars.

Authors:  Mounir J Haurani; Kenneth Foreman; James J Yang; Aamir Siddiqui
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

8.  Ingenol mebutate treatment in keloids.

Authors:  Bruna De Felice; Marco Guida; Luigi Boccia; Massimo Nacca
Journal:  BMC Res Notes       Date:  2015-09-22

9.  Epidermal stem cells cultured on collagen-modified chitin membrane induce in situ tissue regeneration of full-thickness skin defects in mice.

Authors:  Yan Shen; Libing Dai; Xiaojian Li; Rong Liang; Guangxiong Guan; Zhi Zhang; Wenjuan Cao; Zhihe Liu; Shirley Mei; Weiguo Liang; Shennan Qin; Jiake Xu; Honghui Chen
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

10.  Mortalin deficiency suppresses fibrosis and induces apoptosis in keloid spheroids.

Authors:  Won Jai Lee; Hyo Min Ahn; Youjin Na; Renu Wadhwa; JinWoo Hong; Chae-Ok Yun
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.